Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pancreatic Juice and Secretion01:26

Pancreatic Juice and Secretion

3.1K
Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
3.1K
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

1.3K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.3K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

750
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
750
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

376
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
376
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

881
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
881
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

2.6K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Musculoskeletal Pain in Surgeons on Operating Days.

The American surgeon·2026
Same author

Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis.

Neurology·2026
Same author

De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis.

Neurology·2025
Same author

Racial Inequities, Multiple Sclerosis, and Implementation of a Novel Treatment Algorithm at the Health System Level.

Neurology·2025
Same author

Incidence and prevalence of neuromyelitis optica spectrum disorder in a contemporary, multi-ethnic cohort.

Multiple sclerosis (Houndmills, Basingstoke, England)·2025
Same journal

Small-Bites Closure in Emergency Laparotomy.

JAMA surgery·2026
Same journal

Small-Bites Closure in Emergency Laparotomy.

JAMA surgery·2026
Same journal

Whole-Blood Transfusion From Empiricism to Evidence: A Narrative Review.

JAMA surgery·2026
Same journal

Single-Encounter Augmented Reality-Guided Localization for Resection of Suspected Early-Stage Lung Cancer: A Randomized Clinical Trial.

JAMA surgery·2026
Same journal

Augmented Reality, Thoracic Surgery, and Improving the Patient Experience.

JAMA surgery·2026
Same journal

Small-Bites Closure in Emergency Laparotomy.

JAMA surgery·2026
See all related articles

Related Experiment Video

Updated: Feb 9, 2026

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis
11:07

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: September 5, 2025

921

Gallstone pancreatitis without cholecystectomy.

Stephanie S Hwang1, Bonnie H Li, Philip I Haigh

  • 1Department of Surgery, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.

JAMA Surgery
|July 26, 2013
PubMed
Summary
This summary is machine-generated.

Patients not receiving cholecystectomy after gallstone pancreatitis face significant recurrence risk. Endoscopic retrograde cholangiopancreatography (ERCP) reduces this risk, making it a valuable consideration during initial hospitalization.

More Related Videos

The Role of Indocyanine Green Fluorescence in Complex Laparoscopic Cholecystectomy Navigation
03:27

The Role of Indocyanine Green Fluorescence in Complex Laparoscopic Cholecystectomy Navigation

Published on: January 31, 2025

1.3K
Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis
08:10

Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: December 14, 2019

11.7K

Related Experiment Videos

Last Updated: Feb 9, 2026

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis
11:07

Robotic-assisted Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: September 5, 2025

921
The Role of Indocyanine Green Fluorescence in Complex Laparoscopic Cholecystectomy Navigation
03:27

The Role of Indocyanine Green Fluorescence in Complex Laparoscopic Cholecystectomy Navigation

Published on: January 31, 2025

1.3K
Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis
08:10

Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis

Published on: December 14, 2019

11.7K

Area of Science:

  • Gastroenterology
  • Hepatology
  • Surgical Outcomes

Background:

  • Gallstone pancreatitis guidelines recommend cholecystectomy after an initial episode.
  • A significant number of patients do not undergo recommended cholecystectomy due to various factors.

Purpose of the Study:

  • To assess the risk of recurrent gallstone pancreatitis in patients who do not undergo cholecystectomy.
  • To evaluate the impact of endoscopic retrograde cholangiopancreatography (ERCP) on recurrent gallstone pancreatitis risk.

Main Methods:

  • Retrospective cohort study utilizing electronic medical records from Kaiser Permanente Southern California.
  • Inclusion criteria: patients with acute gallstone pancreatitis (1995-2010) without prior diagnosis.
  • Interventions compared: ERCP with or without sphincterotomy/stent placement versus no intervention.

Main Results:

  • 1119 patients identified; median age 63 years.
  • ERCP group (317 patients) had a lower recurrence risk (8.2%) compared to the no-intervention group (17.1%) (P < .001).
  • Kaplan-Meier estimates showed significantly lower 1, 2, and 5-year recurrence rates for ERCP versus no intervention (HR=0.45).

Conclusions:

  • Recurrent gallstone pancreatitis risk is substantial in patients foregoing cholecystectomy.
  • Endoscopic retrograde cholangiopancreatography (ERCP) significantly mitigates this recurrence risk.
  • ERCP should be considered during initial hospitalization for patients not undergoing cholecystectomy.